維力生活科技(01703.HK)中期收益約1.77億港元 同比增加約54.7%
格隆匯3月7日丨維力生活科技(01703.HK)公告,截至2023年9月30日止6個月未經審覈中期業績,收益爲約1.77億港元,增加約54.7%。期內溢利爲約480萬港元(截至2022年9月30日止6個月:虧損約1460萬港元),增加約133.2%。每股盈利爲約0.42港仙(截至2022年9月30日止6個月:每股虧損約(1.27)港仙),增加約133.1%。董事會並不建議就截至2023年9月30日止6個月派付任何股息。
該收益增加乃主要由於香港政府於COVID-19下實施的社交距離措施自2022年12月底起有所放寬,導致客戶數量及本集團提供的宴會服務數量增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.